Navigating portal hypertension: Unlocking safe passage to healthy pregnancy in EHPVO.
neonatal outcomes
obstetric outcomes
portal hypertension
upper GI bleed
Journal
Liver international : official journal of the International Association for the Study of the Liver
ISSN: 1478-3231
Titre abrégé: Liver Int
Pays: United States
ID NLM: 101160857
Informations de publication
Date de publication:
27 Nov 2023
27 Nov 2023
Historique:
revised:
03
10
2023
received:
17
08
2023
accepted:
02
11
2023
medline:
27
11
2023
pubmed:
27
11
2023
entrez:
27
11
2023
Statut:
aheadofprint
Résumé
Pregnancy is associated with hyperdynamic circulatory state and increased risk of portal hypertension related complications in patients with extra-hepatic portal vein obstruction (EHPVO). We aim to study the impact of EHPVO on pregnancy-related outcomes with focus on subset of patients with UGIB (upper GI bleed). Retrospective analysis of obstetric, maternal and neonatal outcomes of patients with EHPVO registered between January 2006 and December 2022. Forty-five patients were included. Forty-five healthy females with low-risk pregnancies formed the control group. Adverse obstetric and neonatal outcomes were comparable between EHPVO and control group (22% vs. 28.6%; p > .05; low birth weight/ small for gestational age 17.8% vs. 36%, p = .0918 and 14.2% vs. 10%, p = .5698 respectively). Adverse outcomes were similar in patients with and without history of UGIB (26.3% vs. 19.4%, p = .0814; 17.8% vs. 36%, p = .0918; 14.2% vs. 10%, p = .5698). There was no maternal mortality in both the groups. A total of 7% pregnancies in EHPVO patients were complicated by ascites. EHPVO pregnancies have successful obstetric and neonatal outcomes with adequate management of portal hypertension.
Sections du résumé
BACKGROUND AND AIMS
OBJECTIVE
Pregnancy is associated with hyperdynamic circulatory state and increased risk of portal hypertension related complications in patients with extra-hepatic portal vein obstruction (EHPVO). We aim to study the impact of EHPVO on pregnancy-related outcomes with focus on subset of patients with UGIB (upper GI bleed).
METHODS
METHODS
Retrospective analysis of obstetric, maternal and neonatal outcomes of patients with EHPVO registered between January 2006 and December 2022. Forty-five patients were included. Forty-five healthy females with low-risk pregnancies formed the control group.
RESULTS
RESULTS
Adverse obstetric and neonatal outcomes were comparable between EHPVO and control group (22% vs. 28.6%; p > .05; low birth weight/ small for gestational age 17.8% vs. 36%, p = .0918 and 14.2% vs. 10%, p = .5698 respectively). Adverse outcomes were similar in patients with and without history of UGIB (26.3% vs. 19.4%, p = .0814; 17.8% vs. 36%, p = .0918; 14.2% vs. 10%, p = .5698). There was no maternal mortality in both the groups. A total of 7% pregnancies in EHPVO patients were complicated by ascites.
CONCLUSIONS
CONCLUSIONS
EHPVO pregnancies have successful obstetric and neonatal outcomes with adequate management of portal hypertension.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Khanna R, Sarin SK. Non-cirrhotic portal hypertension-diagnosis and management. J Hepatol. 2014;60(2):421-441.
de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C, Baveno VII Faculty. Baveno VII-renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959-974.
Goel A, Madhu K, Zachariah U, et al. A study of aetiology of portal hypertension in adults (including the elderly) at a tertiary centre in southern India. Indian J Med Res. 2013;137(5):922-927.
Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol. 2016;64(4):933-945.
Chawanpaiboon S, Vogel JP, Moller AB, et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob Health. 2019;7(1):e37-e46.
Subbaiah M, Kumar S, Roy KK, Sharma JB, Singh N. Extrahepatic portal-vein obstruction in pregnancy. Taiwan J Obstet Gynecol. 2015;54(4):394-397.
Hill CC, Pickinpaugh J. Physiologic changes in pregnancy. Surg Clin North Am. 2008;88(2):391-401, vii.
Clapp JF 3rd, Stepanchak W, Tomaselli J, Kortan M, Faneslow S. Portal vein blood flow-effects of pregnancy, gravity, and exercise. Am J Obstet Gynecol. 2000;183(1):167-172.
Flemming JA, Mullin M, Lu J, et al. Outcomes of pregnant women with cirrhosis and their infants in a population-based study. Gastroenterology. 2020;159(5):1752-1762.e10.
Huang AC, Grab J, Flemming JA, Dodge JL, Irani RA, Sarkar M. Pregnancies with cirrhosis are rising and associated with adverse maternal and perinatal outcomes. Am J Gastroenterol. 2022;117(3):445-452.
Bell H, Raknerud N, Falch JA, Haug E. Inappropriately low levels of gonadotrophins in amenorrhoeic women with alcoholic and non-alcoholic cirrhosis. Eur J Endocrinol. 1995;132(4):444-449.
Sarin SK, Agarwal SR. Extrahepatic portal vein obstruction. Semin Liver Dis. 2002;22(1):43-58.
Aggarwal N, Chopra S, Raveendran A, Suri V, Dhiman RK, Chawla YK. Extra hepatic portal vein obstruction and pregnancy outcome: largest reported experience. J Obstet Gynaecol Res. 2011;37(6):575-580.
Jacob SE, Shankar R, John A, Eapen CE, Yadav B, Rathore S. Maternal and neonatal outcomes in extra hepatic portal vein obstruction: our experience. J Family Med Prim Care. 2021;10(7):2608-2613.
Giri S, Sahoo S, Sundaram S, Shukla A. Maternal and fetal outcomes in pregnant patients with non-cirrhotic portal hypertension: a systematic review and meta-analysis. Obstet Med. 2023;16(3):170-177.
Mandal D, Dattaray C, Sarkar R, Mandal S, Choudhary A, Maity TK. Is pregnancy safe with extrahepatic portal vein obstruction? An analysis. Singapore Med J. 2012;53(10):676-680.
Hoekstra J, Seijo S, Rautou PE, et al. Pregnancy in women with portal vein thrombosis: results of a multicentric European study on maternal and fetal management and outcome. J Hepatol. 2012;57(6):1214-1219.